揭示大动脉狭窄与动脉硬化之间的联系:我们学到了什么?
Corina Cinezan1,2, Camelia Bianca Rus1,2,3, Ioana Tiberia Ilias1,2
1Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
Medicina (Kaunas, Lithuania)
|August 28, 2025
概括
大动脉狭窄与动脉样硬化有着共同的机制,但治疗方法不同. 根据心血管疾病的见解,早期发现和干预AS至关重要.
科学领域:
- 心脏病学
- 血管生物学
- 翻译医学
背景情况:
- 动脉狭窄 (AS) 传统上被视为一种退行性疾病,主要影响老年男性.
- 新出现的证据将AS与动脉样硬化联系在一起,共享风险因素和病理途径.
- 这表明有助于早期预防大动脉狭窄.
研究的目的:
- 审查有关AS和动脉样硬化的共享机制的文献.
- 探索常见的危险因素,致病途径和治疗策略.
- 评估动脉样硬化治疗对AS的疗效.
主要方法:
- 对现有文献进行叙述性回顾.
- 临床试验和转化研究的综合.
- 专注于炎症,脂质介导和化途径.
主要成果:
- 动脉样硬化和动脉样硬化有着共同的炎症,脂质和性机制.
- 动脉样硬化的治疗方法如他类药物对AS有不一致的益处.
- 新疗法旨在延迟大动脉置换并降低患病率.
结论:
- 尽管AS和动脉样硬化具有共同的发病因子,但它们的临床过程和治疗反应不同.
- 了解重叠的局限性和潜力可以指导未来的附加值策略.
- 早期发现AS和有针对性的干预是关键,由心血管疾病管理提供信息.
相关概念视频
Atherosclerosis I: Introduction
76
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
76
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Aortic Regurgitation I: Introduction
36
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54


